about
Plant sterols-enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective studyValidation of serum biomarkers derived from proteomic analysis for the early screening of preeclampsia.Insulin-like growth factor (IGF)-I and insulin in normal and growth-restricted mother/infant pairsIncreased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.Urinary leukotriene E4 levels in atopic and non-atopic preschool children with recurrent episodic (viral) wheezing: a potential marker?Clara cell protein in full-term pregnancies: the influence of intrauterine growth restriction.Midtrimester amniotic fluid concentrations of angiogenic factors in relation to maternal, gestational and neonatal characteristics in normal pregnancies.Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.Serum hepcidin and ferritin to iron ratio in evaluation of bacterial versus viral infections in children: a single-center study.Biochemical markers of bone resorption are present in human milk: implications for maternal and neonatal bone metabolism.Adropin concentrations in term pregnancies with normal, restricted and increased fetal growth.Novel bioactive substances in human colostrum: could they play a role in postnatal adaptation?Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.Fetal concentrations of the growth factors TGF-α and TGF-β1 in relation to normal and restricted fetal growth at term.Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth.Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment.Serum cystatin C in pregnancies with normal and restricted fetal growthN-terminal parathyroid hormone-related protein levels in human intrauterine growth restricted pregnanciesThe potential role of the lectin pathway of complement in the host defence of full-term intrauterine growth restricted neonates at birthSerum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growthPerinatal collagen turnover markers in intrauterine growth restrictionCord blood intestinal fatty acid-binding protein (I-FABP) in full-term intrauterine growth restricted pregnanciesOmentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnanciesCalprotectin in human cord blood: relation to perinatal parameters and restricted fetal growthCirculating concentrations of α- and β-chemokines in neonatal sepsisIntrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1Cord blood irisin at the extremes of fetal growthCystatin-C levels in healthy children and adolescents: Influence of age, gender, body mass index and blood pressureImmunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groupsCord blood netrin-1 and -4 concentrations in term pregnancies with normal, restricted and increased fetal growth
P50
Q33602215-EDFB388D-54E9-425B-B961-1ED538BAB7E3Q34987751-E5D0F21F-8B93-4C0C-BADE-FE7D313D4783Q35752990-F5DEB53F-1E2C-4BDD-B16E-AEA5D47033ADQ38808310-6DEA1FE0-02C7-4968-90A9-77DA027F5AEEQ40815830-AA848D0B-1D8B-44CA-80BE-0B0CC1DEE4D8Q41653037-BFCA7F78-2540-48EE-9553-52A744041552Q43464726-BBAD7D00-71BF-4213-B9B4-FB411972484BQ45461822-ECD15FD0-A65D-4EFA-A90D-DDFDFBEACAE4Q46406712-A7E950F1-F673-4F1C-948A-793CACE4F162Q47857617-D1401206-0068-4215-B3CB-64CB9BA661F1Q50642672-EECE55C4-F4CD-4D2F-9358-61955124E1A4Q50969224-4A3B3389-6DB9-47EF-B1AA-4B6447577EEBQ51533020-FF9C2A87-7ECA-4F1C-9E28-5A22E5F4ECF3Q52665617-BD77A87E-BC38-4661-AAE1-BC23F58F1AD0Q53160871-44925101-4874-4278-870F-2404F39CBC20Q53802543-A60BC1D2-E8A6-47CC-8837-0204A8D28BD9Q54160220-542CC185-5756-4858-A518-914DED040FC7Q80628923-F682B9AE-D30E-456D-B2C9-4F4990FB8D72Q80676603-C959B6FA-187F-4719-8182-7FB0B3B61504Q82498907-969A6403-1711-4285-8FDC-ED2B4642E0FCQ82714348-3294A6F8-5742-4CD9-BB34-726AF325D712Q83459191-9C509685-B9F6-4D82-BA17-B0FF58904EC7Q83899933-AD15DCBA-AEDA-4EDB-A8D0-99074F819E8CQ84270142-7C3C2847-6885-4DB7-A808-A63153FEB5C8Q84567296-5F3901FA-9425-43D8-98C1-F4AAD1FFDDA6Q84661788-DECC8AD9-A0B2-4DC0-A352-92D589245E4BQ84978813-1ED9B933-80B1-48B6-8C81-0632D58CA97DQ85983571-D02CFFBD-5DA2-4F41-BF29-3DAC2CDA19C0Q86566154-603926C8-470F-4323-8EF6-246CD1617A6AQ87499575-949E0A8E-3F18-48C9-80C9-6C7C68BE2204Q87645124-91F99ADE-DE30-49B1-BB9E-748C36C10852
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonios Marmarinos
@ast
Antonios Marmarinos
@en
Antonios Marmarinos
@es
Antonios Marmarinos
@nl
type
label
Antonios Marmarinos
@ast
Antonios Marmarinos
@en
Antonios Marmarinos
@es
Antonios Marmarinos
@nl
prefLabel
Antonios Marmarinos
@ast
Antonios Marmarinos
@en
Antonios Marmarinos
@es
Antonios Marmarinos
@nl
P106
P31
P496
0000-0003-4483-8334